2019 Wendy and Emery Reves International Breast Cancer Symposium

Join the Harold C. Simmons Comprehensive Cancer Center on September 20-21, 2019, for the Reves International Breast Cancer Symposium.

 

External Registrants   UTSW Registrants Only

Overview

The Reves Symposium is a premier event at UT Southwestern Simmons Cancer Center whose objectives are to review the most recent progress in breast cancer, clinical trials, and clinical care of patients with breast cancer. The Reves Symposium provides information on the most current laboratory-based translational discoveries, while also addressing the latest developments in treatment options for patients, and population sciences. World-renowned leaders in the field will share information on:

  • Drug Resistance
  • De-Escalation of Therapy
  • Latest Clinical Trials
  • New Standards of Care

Target Audience

Attendees include laboratory-based translational scientists, physician-scientists, clinical trialists, breast cancer care providers and nursing professionals, laboratory-based postdoctoral and clinical fellows, graduate students, patient advocates, and interested individuals from industry, regulatory agencies, and North Texas communities and beyond.

View the Agenda

Keynote Speakers

Lisa Carey, M.D.
Lisa Carey, M.D.

University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center

Carlos Caldas, M.D.
Carlos Caldas, M.D.

University of Cambridge
Cancer Research UK Cambridge Institute

 

Meet the Presenters

Armando Giuliano, M.D.

 

Armando Giuliano, M.D.

Cedars-Sinai

Rinath Jeselsohn, M.D.

 

Rinath Jeselsohn, M.D. 

Dana Farber Cancer Institute/Harvard

Andrew Koff, Ph.D.

 

Andrew Koff, Ph.D.

Sloan Kettering Institute

W. Lee Kraus, Ph.D.

 

W. Lee Kraus, Ph.D.

UT Southwestern/Simmons Comprehensive Cancer Center

Debra L. Monticciolo, M.D.

 

Debra L. Monticciolo, M.D.

Baylor Scott & White Medical Center

Nicholas Navin, Ph.D.

 

Nicholas Navin, Ph.D.

UT MD Anderson Cancer Center

Robert M. Nishikawa, Ph.D.

 

Robert M. Nishikawa, Ph.D.

University of Pittsburgh

Funmi-Olopade, M.D.

 

Olufunmilayo (Funmi) Olopade, M.D.

 

University of Chicago

Kornella Polyak, M.D., Ph.D.

 

 

Kornelia Polyak, M.D., Ph.D.

Harvard Stem Cell Institute

Timothy Rebbeck, Ph.D.

 

Timothy R. Rebbeck, Ph.D.

Dana-Farber/Harvard Cancer Center

Hope S. Rugo, M.D.

 

Hope S. Rugo, M.D.

UCSF Helen Diller Family Comprehensive Cancer Center

Joseph A. Sparano, M.D.

 

Joseph A. Sparano, M.D.

Albert Einstein College of Medicine

Charles Swanton, M.D., Ph.D.

 

Charles Swanton, M.D., Ph.D.

The Francis Crick Institute

Sara M. Tolaney, M.D., M.P.H.

 

Sara M. Tolaney, M.D., M.P.H.

Dana Farber Cancer Institute/Harvard

Nicholas Turner, M.D., Ph.D.

 

Nicholas C. Turner, M.D., Ph.D. 

The Institute of Cancer Research

Nikhil Wagle, M.D.

 

Nikhil Wagle, M.D.

Dana-Farber/Harvard Cancer Center


Presenters’ Topics

  • Tumor Heterogeneity
  • Advances in Surgery
  • Metabolism
  • Drug Resistance
  • Cell Cycle and CDK4/6 Inhibitors
  • Population Science, Cancer Risk, and Health Disparities
  • De-escalation of Therapy
  • Breast Cancer Detection/Imaging
  • Steroid Nuclear Receptors – and more

 For more information, contact 214-648-9664 / [SCCCEvents@UTSouthwestern.edu].